Inogen

157 articles with Inogen

• Inogen Announces Appointment of Chief Medical Officer

  6/8/2021

  Dr. Stanislav Glezer to join as Executive Vice President and Chief Medical Officer Effective June 21, 2021 at Inogen, Inc.

• Inogen Strengthens Board of Directors with Addition of Elizabeth Mora

  5/24/2021

  Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced that Elizabeth Mora has been appointed to its Board of Directors, effective May 24, 2021.

• Inogen Announces Participation in the 41st Annual William Blair Virtual Growth Stock Conference

  5/12/2021

  Inogen Announces Participation in the 41 st Annual William Blair Virtual Growth Stock Conference

• Inogen Announces First Quarter 2021 Financial Results

  5/4/2021

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three months ended March 31, 2021.

• Inogen to Announce First Quarter 2021 Financial Results on May 4th, 2021

  4/19/2021

  Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2021 financial results after market close on Tuesday, May 4th, 2021.

• Inogen Announces Appointment of Chief Commercial Officer, Transition of Certain Officers, and Preliminary, Unaudited First Quarter 2021 Revenue Range

  4/7/2021

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed George Parr as Inogen’s Executive Vice President and Chief Commercial Officer, effective April 12, 2021.

• Inogen Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

  4/6/2021

  Inogen Announces Participation in the 20 th Annual Needham Virtual Healthcare Conference

• Inogen Announces Participation in the KeyBanc Life Sciences & MedTech Investor Forum

  3/12/2021

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the KeyBanc Life Sciences & MedTech Investor Forum.

• Inogen Announces Fourth Quarter 2020 Financial Results

  2/24/2021

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three- and twelve-month periods ended December 31, 2020.

• Inogen Strengthens Board of Directors with Addition of Kristen Miranda

  2/16/2021

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Kristen Miranda has been appointed to its Board of Directors, effective March 1, 2021. In addition, Ms. Miranda was appointed to the Board’s Compensation Committee.

• Inogen Announces Participation in the 10th Annual SVB Leerink Global Healthcare Conference

  2/10/2021

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 10th Annual SVB Leerink Healthcare Conference.

• Inogen to Announce Fourth Quarter and Year End 2020 Financial Results on February 24th, 2021

  2/9/2021

  Inogen to Announce Fourth Quarter and Year End 2020 Financial Results on February 24 th , 2021

• Inogen Announces CEO Transition

  1/27/2021

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Nabil Shabshab as Inogen’s President and Chief Executive Officer (“CEO”), effective February 8, 2021

• Inogen Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference

  12/18/2020

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 39th Annual J.P. Morgan Healthcare Conference

• Inogen Announces Participation in the Stifel 2020 Virtual Healthcare Conference

  11/10/2020

  Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the Stifel 2020 Virtual Healthcare Conference. Inogen’s President and CEO, Scott Wilkinson, and CFO, Alison Bauerlein, are scheduled to present on Tuesday, November 17 th , 2020 at 4:00 p.m. EST at the Stifel 2020

• Inogen Announces Third Quarter 2020 Financial Results

  11/4/2020

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended September 30, 2020.

• Inogen to Announce Third Quarter 2020 Financial Results on Wednesday, November 4th, 2020

  10/14/2020

  Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2020 financial results after market close on Wednesday, November 4 th , 2020. The Company will host a corresponding conference call beginning at 1:30pm PT

• Inogen Announces Second Quarter 2020 Financial Results

  8/4/2020

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended June 30, 2020.

• Inogen to Announce Second Quarter 2020 Financial Results on Tuesday, August 4th, 2020

  7/7/2020

  Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2020 financial results after market close on Tuesday, August 4th, 2020.

• Inogen CEO Announces Intent to Retire Before End of 2021; Inogen Commences Search for Successor

  6/9/2020

  Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that in connection with Inogen’s succession planning activities, Scott Wilkinson, the Company’s Chief Executive Officer and President, has informed the Company’s Board of Directors